These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 16251880)

  • 1. Galectin-3 immunodetection in follicular thyroid neoplasms: a prospective study on fine-needle aspiration samples.
    Collet JF; Hurbain I; Prengel C; Utzmann O; Scetbon F; Bernaudin JF; Fajac A
    Br J Cancer; 2005 Nov; 93(10):1175-81. PubMed ID: 16251880
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic value of galectin-3 as a marker for malignancy in follicular patterned thyroid lesions.
    Oestreicher-Kedem Y; Halpern M; Roizman P; Hardy B; Sulkes J; Feinmesser R; Stern Y
    Head Neck; 2004 Nov; 26(11):960-6. PubMed ID: 15386597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Galectin-3-expression analysis in the surgical selection of follicular thyroid nodules with indeterminate fine-needle aspiration cytology: a prospective multicentre study.
    Bartolazzi A; Orlandi F; Saggiorato E; Volante M; Arecco F; Rossetto R; Palestini N; Ghigo E; Papotti M; Bussolati G; Martegani MP; Pantellini F; Carpi A; Giovagnoli MR; Monti S; Toscano V; Sciacchitano S; Pennelli GM; Mian C; Pelizzo MR; Rugge M; Troncone G; Palombini L; Chiappetta G; Botti G; Vecchione A; Bellocco R;
    Lancet Oncol; 2008 Jun; 9(6):543-9. PubMed ID: 18495537
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Expression and clinical significance of galectin-3 in well-differentiated thyroid carcinoma].
    Ouyang D; Chen FJ; Wei MW; Yang AK; Chen ZQ; Li QL; Chen YF
    Ai Zheng; 2005 Nov; 24(11):1367-71. PubMed ID: 16552965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of thyroid 'follicular neoplasms' in fine-needle aspiration cytological specimens using a panel of immunohistochemical markers: a proposal for clinical application.
    Saggiorato E; De Pompa R; Volante M; Cappia S; Arecco F; Dei Tos AP; Orlandi F; Papotti M
    Endocr Relat Cancer; 2005 Jun; 12(2):305-17. PubMed ID: 15947105
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Galectin-3 expression in follicular tumours: an immunohistochemical study of its use as a marker of follicular carcinoma.
    Ito Y; Yoshida H; Tomoda C; Miya A; Kobayashi K; Matsuzuka F; Yasuoka H; Kakudo K; Inohara H; Kuma K; Miyauchi A
    Pathology; 2005 Aug; 37(4):296-8. PubMed ID: 16194828
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Galectin-3 is a presurgical marker of human thyroid carcinoma.
    Orlandi F; Saggiorato E; Pivano G; Puligheddu B; Termine A; Cappia S; De Giuli P; Angeli A
    Cancer Res; 1998 Jul; 58(14):3015-20. PubMed ID: 9679965
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Utility of galectin 3 expression in thyroid aspirates as a diagnostic marker in differentiating benign from malignant thyroid neoplasms.
    Aron M; Kapila K; Verma K
    Indian J Pathol Microbiol; 2006 Jul; 49(3):376-80. PubMed ID: 17001889
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of galectin-3 in fine-needle aspirates as a diagnostic marker differentiating benign from malignant thyroid neoplasms.
    Inohara H; Honjo Y; Yoshii T; Akahani S; Yoshida J; Hattori K; Okamoto S; Sawada T; Raz A; Kubo T
    Cancer; 1999 Jun; 85(11):2475-84. PubMed ID: 10357421
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hexokinase III, cyclin A and galectin-3 are overexpressed in malignant follicular thyroid nodules.
    Hooft L; van der Veldt AA; Hoekstra OS; Boers M; Molthoff CF; van Diest PJ
    Clin Endocrinol (Oxf); 2008 Feb; 68(2):252-7. PubMed ID: 17868400
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Galectin-3 immunodetection in thyroid fine-needle aspirates: technical procedure and results].
    Collet JF; Fajac A
    Ann Pathol; 2006 Oct; 26(5):347-51. PubMed ID: 17255922
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunocytochemical evaluation of thyroid neoplasms on thin-layer smears from fine-needle aspiration biopsies.
    Rossi ED; Raffaelli M; Minimo C; Mule A; Lombardi CP; Vecchio FM; Fadda G
    Cancer; 2005 Apr; 105(2):87-95. PubMed ID: 15742329
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Galectin-3 and CD44v6 as markers for preoperative diagnosis of thyroid cancer by RT-PCR.
    Samija I; Mateša N; Lukač J; Kusić Z
    Diagn Mol Pathol; 2011 Dec; 20(4):233-41. PubMed ID: 22089351
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Usefulness of galectin-3 immunohistochemistry in differential diagnosis between thyroid follicular carcinoma and follicular adenoma.
    Jakubiak-Wielganowicz M; Kubiak R; Sygut J; Pomorski L; Kordek R
    Pol J Pathol; 2003; 54(2):111-5. PubMed ID: 14575419
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Follicular thyroid neoplasms can be classified as low- and high-risk according to HBME-1 and Galectin-3 expression on liquid-based fine-needle cytology.
    Fadda G; Rossi ED; Raffaelli M; Pontecorvi A; Sioletic S; Morassi F; Lombardi CP; Zannoni GF; Rindi G
    Eur J Endocrinol; 2011 Sep; 165(3):447-53. PubMed ID: 21724837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The significance of Galectin-3 expression in the immunocytochemical evaluation of thyroid fine needle aspiration cytology.
    Ersoz S; Sert H; Yandi M; Erem C; Mungan S; Ersoz HO; Cobanoglu U; Hacihasanoglu A
    Pathol Oncol Res; 2008 Dec; 14(4):457-60. PubMed ID: 18415710
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Galectin-3 is not useful in thyroid FNA.
    Mills LJ; Poller DN; Yiangou C
    Cytopathology; 2005 Jun; 16(3):132-8. PubMed ID: 15924608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Galectin-3: presurgical marker of thyroid follicular epithelial cell-derived carcinomas.
    Saggiorato E; Aversa S; Deandreis D; Arecco F; Mussa A; Puligheddu B; Cappia S; Conticello S; Papotti M; Orlandi F
    J Endocrinol Invest; 2004 Apr; 27(4):311-7. PubMed ID: 15233548
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Galectin-3 does not reliably distinguish benign from malignant thyroid neoplasms.
    Mehrotra P; Okpokam A; Bouhaidar R; Johnson SJ; Wilson JA; Davies BR; Lennard TW
    Histopathology; 2004 Nov; 45(5):493-500. PubMed ID: 15500653
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intensity and distribution of immunohistochemical expression of galectin-3 in thyroid neoplasms.
    Matesa-Anić D; Moslavac S; Matesa N; Cupić H; Kusić Z
    Acta Clin Croat; 2012 Jun; 51(2):237-41. PubMed ID: 23115948
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.